Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa/carbidopa/entacapone vs pramipexole for wearing-off in Parkinson's disease in China
ChiCTR2000039050Phase 4Not yet recruiting
- Sponsor
- Affiliated Brain Hospital of Nanjing Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Parkinson's disease (PD) comparing Pramipexole add-on with Levodopa/carbidopa/entacapone regimen (2 arms). Primary endpoint: 'off' time. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
carbidopa/levodopa/entacaponepramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR2000039050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039050.